The Effect of PHGG-rich Enteral Nutrition to on the Infection in Liver Transplant Recipients: A Prospective, Double-blind, Randomized Controlled Study

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05543226

Enrollment

136

Registered

2022-09-16

Start date

2022-10-01

Completion date

2024-09-30

Last updated

2022-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections

Brief summary

To known the effect of PHGG-rich enteral nutrition to on the infection in liver transplant recipients

Interventions

DRUGPHGG-rich enteral nutrtiion

PHGG-rich enteral nutrition

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. liver transplant recipients 2. age from 18 to 80 years old 3. APACHE II score \>12 4. There is an indication for enteral nutrition and it is expected to require oral or tube feeding for more than 7 days 5. there is no intra-abdominal infection or bloodstream infection

Exclusion criteria

1. Severe cardiac, kidney and lung dysfunction 2. bowel obstruction, intestinal perforation, intestinal leakage before operation 3. Roux and Y anastomosis during liver transplant

Design outcomes

Primary

Measure	Time frame	Description
Incidence of infections after liver transplantation	30 days	the incidence of infections after 30 days of the liver transplantation

Contacts

Primary ContactQing He

heqing@mail.sysu.edu.cn+8613710329468

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026